Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Profit After Tax

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year Profit After Tax History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit After Tax ₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr

What is the latest Profit After Tax of TORRENT PHARMACEUTICALS ?

The latest Profit After Tax ratio of TORRENT PHARMACEUTICALS is ₹1,656 Cr based on Mar2025 Consolidated results.
Year Profit After Tax
Mar2025₹1,656 Cr
Mar2024₹1,245 Cr
Mar2023₹777 Cr
Mar2022₹1,252 Cr
Mar2021₹1,025 Cr

How is Profit After Tax of TORRENT PHARMACEUTICALS Trending?

Years Profit After Tax % Change
Mar2025 ₹1,656 Cr
33.02
Mar2024 ₹1,245 Cr
60.22
Mar2023 ₹777 Cr
-37.92
Mar2022 ₹1,252 Cr
22.17
Mar2021 ₹1,025 Cr -

Compare Profit After Tax of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹145,395.3 Cr 2.1% -0.4% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics
MANKIND PHARMA ₹83,401.6 Cr 1% -1.3% -11.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.1%

-0.4%

31.8%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses